M&A Deal Summary |
|
---|---|
Date | 2021-12-10 |
Target | G Lab |
Sector | Life Science |
Buyer(s) | Eurofins Scientific |
Sellers(s) | Trans Genic |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1987 |
Sector | Life Science |
Employees | 51,516 |
Revenue | 5.4B EUR (2020) |
Eurofins Scientific is an international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins Scientific was incorporated in 1987 and is based in Luxembourg City, Luxembourg.
DEAL STATS | # |
---|---|
Overall | 88 of 95 |
Sector (Life Science) | 66 of 72 |
Type (Divestiture) | 19 of 19 |
Country (Japan) | 3 of 4 |
Year (2021) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-28 |
DNA Diagnostics Center
Fairfield, Ohio, United States DNA Diagnostics Center is a provider of private DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry. DDC provides products approved by the FDA and EMA, and is accredited by the American Association of Blood Banks (AABB), The Ministry of Justice, The College of American Pathologists (CAP), and The Clinical Laboratory Improvement Amendment (CLIA). DNA Diagnostics Center was founded in 1995 and is based in Fairfield, Ohio. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-02-09 |
Genetic
Hanoi, Vietnam Gentis is a specialized genetic testing service provider founded on the principle that technological advancements in DNA testing should be accessible and affordable to everyone. The company provides comprehensive specialized DNA testing services including obstetrical genetics; genealogical DNA tests; oncology; and COVID-19 testing services. It has grown strongly with a reputation for outstanding quality and has become the trusted service provider for more than 100 major hospitals in Vietnam, as well as consumers. Gentis is based in Hanoi, Vietnam. |
Buy | - |
Category | Company |
---|---|
Founded | 1998 |
Sector | Life Science |
Employees | 213 |
Revenue | 12.6B JPY (2022) |
Trans Genic develops, distributes, and licenses genetically engineered animals and antibodies in Japan. The company provides total support for non-clinical and clinical trials, as well as exploratory research, pharmaceuticals, antibody drugs, research and development, and histopathological diagnosis directly linked to clinical practice. Trans Genic was founded in 1998 and is based in Fukuoka, Japan.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Japan) | 1 of 1 |
Year (2021) | 1 of 1 |